Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Peritoneal Mesothelioma, CRS-HIPEC Outcomes

Olivier Glehen

MD, PhD

🏢Centre Hospitalier Lyon-Sud / Universite Claude Bernard Lyon 1🌐France

Professor of Surgery

52
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Olivier Glehen is a French surgical oncologist and pioneer in peritoneal surface oncology who co-founded RENAPE, the French peritoneal surface malignancy registry, and co-chairs PSOGI (Peritoneal Surface Oncology Group International). He has published landmark outcomes data on CRS-HIPEC for malignant peritoneal mesothelioma and contributed the French cohort data to international analyses demonstrating benefit of surgery in carefully selected mesothelioma patients. He actively collaborates on developing systemic therapy guidelines for peritoneal mesothelioma in the immunotherapy era.

Share:

🧪Research Fields 研究领域

malignant peritoneal mesothelioma CRS-HIPEC
peritoneal mesothelioma systemic therapy
PMP France PSOGI data
IPHOP French HIPEC network
peritoneal surface oncology registry

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Olivier Glehen 的研究动态

Follow Olivier Glehen's research updates

留下邮箱,当我们发布与 Olivier Glehen(Centre Hospitalier Lyon-Sud / Universite Claude Bernard Lyon 1)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment